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Molecular Anatomy of a 5q Interstitial Deletion
By Lalitha Nagarajan, Beverly Lange, Linda Cannizzaro, Janet Finan, Peter C. Nowell, and Kay Huebner A truncated granulocyte-macrophage colony-stimulating factor (GM-CSF) allele on a putative 5q-chromosome of HL-60 cells was cloned and, by comparison with counterpart normal sequences, analyzed for clues to molecular mechanisms facilitating rearrangement and deletion. Within the 17-kilobase (kb) pair locus surrounding the truncated GM-CSF gene remnant, there are no fewer than four rearranged genomic fragments that seemingly derive from chromosome 5 region q21423. Two of the fragments, which flank the truncated GM-CSF locus on the 5q-, are contiguous on the normal chromosome 5, centrometric to the normal GM-CSF allele, indicating at least one intrachromosomal insertion event, either preceded or followed by further deletion. Insertion and/or deletion was accompanied by juxtaposition of LINE sequences to the 5' side of the truncated GM-CSF locus within the inserted fragment. The entire rearranged locus is embedded in repetitive sequences, which may have mediated successive insertions CQUIRED PARTIAL deletions of the long arm of A chromosome 5 (5q) occur in myeloproliferative disorders and acute myeloid leukemias; considerable evidence suggests that the 5q-anomaly'.* occurs in a myeloid precursor ell.^.^ Although the limits of these interstitial deletions vary from 5 q l l to 5q23 for the proximal breakpoint and 5q22 to 5q33 or 5q34 for the distal breakpoint, there is a critical region of overlap, ie, a common deleted region near 5q22,5.6 in 5q-cases, suggesting an important role for hemizygosity, conversion to hemizygosity in conjunction with mutation at a remaining allele, or other alteration of a gene or genes at this locus in the evolution of the abnormal phenotype. A remarkable number of growth factor receptor~,~,' growth factors9'I6 and other gene with known or possible relevance to growth, differentiation, or maturation within the myeloid/erythroid lineage, have been mapped in or near the common deleted region of chromosome 5; many of these genes are indeed deleted in some sq-cases7.10-14.1 6-1 8 and some of these genes (eg, granulocyte-macrophage colony-stimulating factor [GM-CSF], interleukin-3 [IL-31, IL-4, and IL-5) may always be de-
The acute myeloblastic leukemia cell line HL-602' is monosomic for chromosome 5 and carries a marker chromoleted,9,10,1 2-14.16 From some, mar3, abnormalities which were identified in addition to several others at the time of diagnosis in the HL-60 patient's bone marrow (BM). The submetacentric marker chromosome, mar3, was the only marker chromosome present at diagnosis.2' We proposed that this marker chromosome, mar3, is entirely derived from chromosome 5 with an interstitial deletion between ql3-q3 1-33, and could thus be a 5q-chromosome.' The recent reevaluation of the HL-60 phenotype2' has shown these cells to be acute myeloblastic leukemia with maturation, French-American-British classification M2 (FAB-M2), rather than acute progranulocytic leukemia, FAB-M3, as originally classified.2' Some acute nonlymphocytic leukemias arising de novo or associated with a preexisting myelodysplastic syndrome exhibit a 5q-chromosome, usually with additional cytogenetic abn~rmalities.'.~ Thus, HL-60 cells could derive from this category of leukemia, an idea instigated by the observation that the HL-60 cell line carried a truncated, rearranged GM-CSF allele that might reside a t one end of the interstitial deletion on mar3, the putative 5q-chromosome.' Thus, analysis of the structure and sequence of the truncated GM-CSF locus of HL-60 cells should allow isolation of loci from both ends of the interstitial deletion and could provide clues to mechanisms involved in generation of such deletions.
MATERIALS AND METHODS

Genomic clones.
Genomic libraries for HL-60 cells and cells from a cell line with normal chromosomes 5 were prepared. DNAs were partially digested with endonuclease Sau3a, ligated to bacteriophage EMBL 3a arms, packaged and screened with appropriate probes as previously de~cribed.**~*~ The HL-60 library was screened with the full-length 5.6 kb Hind111 genomic subclone from the GM-CSF locus? Phages carrying the normal and rearranged GM-CSF loci from HL-60 were isolated and mapped. Repeat-free subclones in pUC vectors from the HL-60 rearranged GM-CSF locus were used to screen the second genomic library from the cell line with normal chromosomes 5 to define the origin of the regions of the HL-60 GM-CSF rearranged locus. All sequencing was performed with the dideoxy chain termination methodz4 as described p r e v i o~s~y .~~ Total cellular DNAs from human and Southern blot analysis. 
RESULTS
The partially deleted GM-CSF allele from HL-60 DNA has been molecularly cloned. Restriction enzyme analysis of this rearranged allele (Fig 1) confirmed that the locus has lost all GM-CSF coding information but carries a 3.1-kb genomic fragment of the 3' flanking region of the GM-CSF locus. From the rearranged phage clone (Fig 1B) that was rich in human repetitive sequences, a repeat-free genomic probe, CPL 2.6, was subcloned from the region upstream of the truncated GM-CSF locus ( Fig IB) and localized to chromosome region 5q21 by somatic cell hybrid analysis and in situ chromosomal hybridization.26 The CPL 2.6 genomic probe detects a frequent Sac1 restriction fragment length polymorphism (RFLP) in the normal human population26 which detects deletion of one CPL 2.6 allele in DNA from tissue samples exhibiting the 5q-abnormality." DNAs shown in Fig 2 (lanes 2 and 9) were from two human cell lines heterozygous for this locus as evidenced by the presence of two distinct genomic fragments (3.5-kb allele A and 2.6-kb allele B; 1.1-kb fragment is a constant fragment); lanes 6 and 7 (Fig 2) , respectively, contained DNA from BM white blood cells (WBCs) and peripheral blood lymphocytes (PBLs) of a normal homozygous individual; lanes 5 and 8 (Fig 2) contained DNA from BM WBCs of two 5q-cases that exhibited hemizygosity at this locus. The presence of both CPL 2.6 alleles in DNA from PBLs of a 5q-leukemia in remission (lane IO) and absence of allele A (3.5 kb) in BM WBCs (lane 11) and PB (lane 12) at relapse demonstrates the potential use of the CPL 2.6 RFLP in monitoring expansion of the 5q-clone in leukemias or myelcdysplastic disorders with acquired interstitial deletions of chromosome 5. HL-60 DNA (Fig 2, lane 3 ) from which this probe was isolated, carries a normal allele A (3.5 kb) and a 7.0-kb rearranged allele. that results in detection of the constant 1 .l-kb fragment and the two polymorphic alleles of 3.5 and 2.6 kb which are due to the S8cl polymorphism; in HL-60, the normal allele is the 3.5-kb s8Cl fragment shown in Fig 3A as PLC 3 .5: the constant 1.1-kb fragment is immediately to the left of PLC 3.5 in Fig 3A .
Surprisingly, another repeat-free genomic probe, CPR 0.5, subcloned from the region downstream of the rearranged GM-CSF locus (Fig 1 B) detected the same Sac1 polymorphism in normal human DNAs and a novel rearranged allele in HL-60 DNA (not shown). To understand the structural 
this observation, the SacI polymorphic locus (NCP) was isolated from a normal chromosome 5 and characterized (Fig 3) . The N C P locus was rich in repetitive sequences except in the region of the 3.5-kb Sac1 fragment, designated PLC 3.5 (Fig 3A) . Analysis of the restriction maps of the normal SacI polymorphic locus (Fig 3A) and the GM-CSF rearranged locus allowed several conclusions. The CPL 2.6 probe is identical to the repeat-free subclone N C P 2.6 from the normal chromosome 5 phage clone (Fig 3A) , and the CPR 0.5 subclone is identical to sequences to the right of N C P (Fig 3A and B) . Thus, the CPL 2.6 and CPR 0.5 fragments within the rearranged GM-CSF locus (Fig 3B) derived from a contiguous fragment of genomic DNA on human chromosome 5. An insertion of a 10-kb segment of genomic DNA has occurred in the middle of the 3.5-kb SacI fragment (PLC 3.5, Fig 3A) of the normal SacI polymorphic locus. The sequences to the left of CPL 2.6 on the HL-60 rearranged clone (Fig 3B) , which contain repeats and thus are unsuitable as probes, are different from sequences on the left of the normal counterpart of CPL 2.6, the N C P fragment (Fig 3A) , as shown by their entirely different restriction maps. In addition, the restriction map of the rearranged GM-CSF genomic clone matches, for each enzyme tested, the restriction map obtained from Southern blots of HL-60 cellular DNA.
Thus, the HL-60 truncated GM-CSF locus contains at least four distinct chromosome breaks and joinings or insertions. Possible molecular mechanisms underlying such complex recombinational events resulting in interstitial chromosomal deletion were investigated by nucleotide sequence analysis at the sites of insertion (Fig 4) . Additional sequencing was performed to determine the nature of the inserted repetitive elements. The data showed that in the HL-60 5q-chromosome the N C P sequences around the site of insertion are A T rich (greater than 60%) and carry a number of mirrored and direct repeats at the site of insertion, as shown in Fig 4. The 12-bp direct repeat (TTCAGGACATGT) pair, preceded by a mirrored repeat, in the right half of the fragment-a sequence (Fig 4) is at least partially complemented at the extreme left of fragment a (CTGAA is the reverse complement of TTCAG and is also, in the reverse 
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direction, preceded by a mirrored repeat). The region between the TTCAGGACATGT direct repeat pair is interrupted by insertion of the 3' end of the GM-CSF locus, and the left member of the repeat pair along with preceding sequences is lost on the 5q-chromosome. Analysis of sequences within the inserted fragment showed that a stretch of at least 200 nucleotides (Fig 4A, fragment d) was identical to the human LINE sequence published by Hattori et a12* (data not shown). The size of the inserted repetitive sequence (6 kb) is similar to that reported for a full-length LINE element, and its AT richness is similar to that reported by Furano et a129 for the rat LINE insertion. Together, these observations suggest that the entire repetitive element, between the rearranged CPL 2.6 and GM-CSF loci, is LINE derived as shown in Fig 4A. The presence of LINE sequences may suggest that because this region of the genome was undergoing recombination it captured a transposable element. Alternatively, the LINE sequences could have been involved in effecting the insertion. Either scenario would result in a deleted chromosome 5 in a precursor cell which thus becomes haploid for gene loci in the critical deleted region. The HL-60 5q-chromosome, which was analyzed in detail in the absence of the normal chromosome 5 in somatic cell hybrid^,^' has lost GM-CSF, IL-3, IL-4, and IL-5 loci, but retains2' FGFA, PDGFR, CSFlR, ADRBR, and CSFl loci which are telomeric to the GM-CSF locus on normal chromosome 527 and the GRL locus which has recently been reassigned to a position telomeric to the GM-CSF locus.27~32-34
Direct evidence for involvement of a specific deleted or otherwise altered gene (GM-CSF, IL-3, or other) in the pathogenesis of the 5q-syndrome is lacking. Sequencing of the normal GM-CSF allele in HL-60 cells did not show point mutations (data not shown); in addition, HL-60 cells express a 1.1-kb GM-CSF transcript when induced to differentiate into granulocytes with TPA (K. Huebner and A. ar-Rushdi, unpublished observations), suggesting that the GM-CSF allele on the unaffected chromosome 5 is functional.
Repeat-free probes from the normal NCP and truncated GM-CSF loci did not detect short-range rearrangements in three other 5q-cases tested, but one NCP allele is consis- g t c x a a a g c c c a c a a t c c agt c a c c a g a g a --c-- tently deleted27 along with an IL-3 and GM-CSF allele. Other 5q-cases in which the C S F l R and CSFl loci are not deleted have been reported.lO*l' Thus, the HL-60 putative 5q-chromosome has the hallmarks of a characteristic 5q-chromosome in which the deletion endpoints we have delineated by molecular analysis, fall inside the larger deletions sometimes observed; conclusions based on molecular analysis of the HL-60 5q deletion may be generally applicable not only for 5q interstitial deletions but for interstitial deletions in other chromosome regions as well.
DISCUSSION
Somatically acquired interstitial deletions in specific chromosomal regions are characteristic of many preneoplastic and neoplastic condition^.^' Understanding of the contributory role of characteristic deletions to etiology of specific tumors through reduction of specific loci to hemizygosity has been clarified by early theoretical consideration^^^,^' and recent molecular ana lyse^,^^-^' but molecular mechanisms responsible for the predisposing deletions have not been studied.
Nucleotide sequences directly involved in deletion have been analyzed in specific cases, especially for some metabolic disorders, and possible genetic mechanisms involved in some of these deletions have been s~ggested,4',~~ but for the generality of acquired large eukaryotic chromosomal deletions mechanisms of generation have not been studied because isolation of the deletion endpoints has not been possible. Elegant studies of deletions in prokaryotic genomes have suggested a mechanism of slipped strand mispairing of short-sequence homologies or repeated short sequences in generation of deletion^^^,^^; one of the repeat sequences involved was a pentanucleotide, CTCTT, which occurs in abbreviated form in our sequence just to the left of the inserted LINE element (Fig 4B) and in several other places in complementary form (GAGAA).
Perhaps the most striking sequence element involved in the HL-60 5q deletion, the 12-bp direct repeats (TTCAGGA-CATGT), are similar (six matching, five complementary nucleotides, one inserted nucleotide) to the hepatitis B direct repeats (TTCACCTCTGC) in the cohesive ends of the viral genome.46 HBV genome integration often takes place in regions between the direct repeat^,"^ and in a t least one case of HBV integration there was a cellular sequence 14 bp from the viral insertion which was the reverse complement of the HBV direct repeat that was the same distance from the viral-host junction:' Variations on the theme TCTCC, or its complement, which occurs within the HBV repeat, appear in several places in the HL-60 rearranged locus, near a deletion in human mitochondrial on both sides of an immunoglobulin A-bcl-2 translo~ation,~~ and near regions involved in immunoglobulin isotype s w i t~h i n g .~~,~~ Thus, although data are too scanty to suggest a detailed mechanism for the HL-60 5q insertion, the traces left by the insertion are tantalizingly suggestive of some intrachromosomal recombinatorial mechanism, perhaps similar to immunoglobulin isotype switching, which could have a physiologic function.
Isolation and analysis of the genomic fragments juxtaposed by the HL-60 5 q deletion, although not yet providing probes to detect rearranged endpoints in other 5q-cases, leads to conclusions that might be relevant to this class of deletions. First, the deletion is not the result of a simple break and rejoining; second, intrachromosomal insertion, possibly mediated by specific sequence elements near the point of insertion, can effect deletion. Certain implied conclusions only.
For personal use at PENN STATE UNIVERSITY on March 1, 2013. bloodjournal.hematologylibrary.org From may also be generally applicable to interstitial deletions: Deletion is not the result of a single event but results instead from several stepwise rearrangements; deletions are not necessarily continuous (ie, remnants of loci internal to the deletion endpoints may remain); we know that several loci centromeric to CPL 2.6 have also been deleted on the HL-60 5q-chrom~some.~' Thus, gene mapping based solely on determination of loci lost or retained in tissues exhibiting chromosomal deletions may lead to errors in gene localization and order.
In summary, we were able to analyze sequences involved in interstitial deletion on the HL-60 5q-chromosome because a previously cloned gene probe detected a nearby rearrangement. Many probes are now available for this region of chromosome 5, and longer range rearrangements might be detected by pulsed-field gel electrophoresis. When new deletion endpoints have been cloned and characterized, recombinatorial signals on deletion substrates may point to specific recombination mechanisms involved in generation of chromosomal interstitial deletions, a major class of genetic abnormality contributing to metabolic and neoplastic diseases of both inherited and sporadic forms.
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